Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies

Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies

US Patent 10648983 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
BET inhibitors as a treatment for myelofibrosis2025
Methods of treating cancer by targeting cold tumors2025
Ionospheric disturbance information generation methods and systems2025
Communication station, optical communication system, data transmission method, a2025